Experts Conflicted on Potential of Breakthrough Therapy Designations

Drug Industry Daily
A A
A new Tufts University report praises the FDA’s breakthrough therapy program for its potential to advance new drugs and biologics targeting unmet needs.

To View This Article:

Login

Subscribe To Drug Industry Daily